CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region

Do Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, Irsan Hasan, Lyana Setiawan, Ming-Lung Yu, Namiki Izumi, Nguyen Nguyen Huyen, Pierce Kah-Hoe Chow, Rosmawati Mohamed, Stephen Lam Chan, Tawesak Tanwandee, Teng-Yu Lee, Thi Thanh Nguyen Hai, Tian Yang, Woo-Chang Lee, Henry Lik Yuen Chan

Clin Mol Hepatol. 2023;29(2):277-292. Published online 2023 January 30 DOI: https://doi.org/10.3350/cmh.2022.0212

Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region

Clinical and Molecular Hepatology. 2023;29(2):277-292

Link1

Link2 Link3

Clinicopathological significance of PIVKA-ii and AFP in hepatocellular carcinoma

T NAKAGAWA

Hepatology. 1995;22(4):A187

Link1 Link2

Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region

Deepak Amarapurkar, Kwang-Hyub Han, Henry Lik-Yuen Chan, Yoshiyuki Ueno,

Journal of Gastroenterology and Hepatology. 2009;24(6):955-961

Link1 Link2

Utility of PIVKA-II and AFP in Differentiating Hepatocellular Carcinoma from Non-Malignant High-Risk Patients

Hana Hadi, Wan Muhammad Azfar Wan Shuaib, Raja Affendi Raja Ali, Hanita Othman

Medicina. 2022;58(8):1015

Link1

Plasma PIVKA-II values as an indicator of AFP mRNA in the circulation in patients with advanced hepatocellular carcinoma

S Nambu

Hepatology Research. 1997;8(1):28-36

Link1 Link2

PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma

Honglei Feng, Bole Li, Ze Li, Qian Wei, Li Ren

BMC Cancer. 2021;21(1):

Link1

Link2 Link3

Clinical Significance of AFP and PIVKA-II Responses for Monitoring Treatment Outcomes and Predicting Prognosis in Patients with Hepatocellular Carcinoma

Hana Park, Jun Yong Park

BioMed Research International. 2013;2013:1-6

Link1

Link2 Link3

Prevention of hepatocellular carcinoma in the Asia-Pacific region: Consensus statements

Journal of Gastroenterology and Hepatology. 2010;25(4):657-663

Link1 Link2

Mo1400 ROLE OF PIVKA-II AND AFP-L3 IN COMBINATION WITH AFP FOR DETECTION AND PREDICTION OF MORTALITY FOR HEPATOCELLULAR CARCINOMA AMONG PATIENTS WITH CIRRHOSIS

Kessarin Thanapirom, Sirinporn Suksawatamnuay, Nopavut Geratikornsupuk, Preeyaporn Witchakul, Nittaya Laobunkue, Panarat Thaimai, Piyawat Komolmit

Gastroenterology. 2020;158(6):S-1395

Link1 Link2

Clinical usefulness of PIVKA-II measured by sensitive enzyme immunoassay and AFP-L3 measured by automated analyzer in the diagnosis of hepatocellular carcinoma (HCC)

Y Paik

Journal of Hepatology. 2001;34:98-99

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.